The C9orf72 gene test for Amyotrophic Lateral Sclerosis (ALS) with Frontotemporal Dementia (FTD) is a specialized genetic test available at DNA Labs UAE, designed to identify expansions in the C9orf72 gene, which are known to be the most common genetic cause of both familial ALS and FTD. This test is crucial for individuals with a family history of these conditions or those exhibiting symptoms, as it aids in the accurate diagnosis and understanding of their risk of developing these neurodegenerative diseases. The test is performed with a high degree of accuracy and confidentiality, ensuring patients receive comprehensive support and information. The cost of the C9orf72 gene test at DNA Labs UAE is 4400 AED, reflecting the sophisticated technology and expertise required to conduct this analysis.
The SS18L1 gene has been implicated in a range of neurological conditions, including Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. The genetic test focusing on the SS18L1 gene's involvement in ALS, particularly in relation to the CREST syndrome - a complex disorder that can include calcinosis, Raynaud's phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia - provides crucial insights for individuals with a family history of ALS or related symptoms.
DNA Labs UAE offers a specialized genetic test targeting the SS18L1 gene to identify mutations that may contribute to the development of ALS and its overlap with CREST-related symptoms. This test is essential for patients seeking a comprehensive understanding of their genetic predisposition to ALS and CREST syndrome, allowing for early intervention, personalized treatment plans, and informed family planning.
The cost of this comprehensive genetic test is 4400 AED. Conducted at DNA Labs UAE, the test involves a simple procedure but offers profound insights into the patient's genetic makeup, potentially guiding crucial health decisions and lifestyle adjustments to manage or mitigate the risk of ALS and related conditions.
The APP Gene Alzheimer Disease Type 1 Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the APP gene, which are strongly linked to the early onset of Alzheimer's disease. Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss, cognitive decline, and behavioral changes. The APP gene encodes the amyloid precursor protein, and mutations in this gene can lead to the abnormal accumulation of amyloid-beta peptides in the brain, a hallmark of Alzheimer's disease.
This genetic test is particularly important for individuals with a family history of early-onset Alzheimer's disease, as it can provide crucial information regarding their risk of developing the condition. Early detection through genetic testing allows for timely intervention and management strategies to slow the progression of the disease and improve the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a leading facility known for its advanced genetic testing services. The cost of the APP Gene Alzheimer Disease Type 1 Genetic Test is 4400 AED. The testing process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for the presence of mutations in the APP gene. The results of this test can guide healthcare professionals in developing personalized care plans for individuals at risk or affected by Alzheimer's disease, focusing on managing symptoms and providing support for the patient and their family.
The NOS3 gene, also known as the endothelial nitric oxide synthase (eNOS) gene, plays a crucial role in vascular function and has been implicated in various cardiovascular diseases. Recent studies suggest that variations in the NOS3 gene may also be linked to Alzheimer's disease type 1, a neurodegenerative disorder characterized by progressive memory loss, cognitive decline, and behavioral changes. The association is thought to be due to the gene's impact on blood flow and nutrient delivery to the brain, influencing the development and progression of Alzheimer's disease.
To explore this genetic link further, DNA Labs UAE offers a specialized genetic test targeting the NOS3 gene in relation to Alzheimer's disease type 1. This test is designed to identify specific mutations or variations within the NOS3 gene that may increase an individual's risk of developing Alzheimer's disease. By analyzing a sample of the patient's DNA, the test can provide valuable insights into their genetic predisposition to this condition.
The cost of the NOS3 Gene Alzheimer Disease Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure, from sample collection to detailed analysis and reporting. Patients who opt for this test can expect a comprehensive evaluation of their genetic risk factors for Alzheimer's disease, enabling them to make informed decisions about their health and potential preventive measures. It's an essential tool for those with a family history of Alzheimer's disease or individuals seeking to understand their genetic health profile better.
The APOE gene Alzheimer's disease type 2 genetic test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify the presence of specific alleles of the APOE gene that are associated with an increased risk of developing Alzheimer's disease. The APOE gene is instrumental in the metabolism of fats in the body and has three common alleles: ε2, ε3, and ε4. The ε4 allele is linked to a higher risk of Alzheimer's disease, while the ε2 allele is considered to provide some protection against the condition.
This test is crucial for individuals with a family history of Alzheimer's disease or those who wish to understand their genetic predisposition to this neurodegenerative disorder. It involves a simple sample collection process, after which the DNA is analyzed to determine the specific APOE alleles present.
The cost of the APOE gene Alzheimer's disease type 2 genetic test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure and a comprehensive report that explains the results and their implications for the individual's risk of developing Alzheimer's disease. It's an invaluable tool for those seeking early intervention strategies or simply peace of mind regarding their genetic health.
The PSEN2 Gene Alzheimer's Disease Type 4 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the PSEN2 gene, which are linked to the development of Alzheimer's disease type 4. This form of Alzheimer's disease is inherited in an autosomal dominant pattern, meaning a mutation in just one copy of the gene in each cell is sufficient to increase an individual's risk of developing the condition. The test is crucial for individuals with a family history of Alzheimer's disease, as it can provide valuable insights into their genetic predisposition to this type of dementia.
The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic variations in the PSEN2 gene that are associated with Alzheimer's disease type 4. The results of this test can help individuals make informed decisions about their health and lifestyle, and in some cases, may lead to the consideration of preventative measures or early interventions.
The cost of the PSEN2 Gene Alzheimer's Disease Type 4 Genetic Test at DNA Labs UAE is 4400 AED. Given the complexity and the specific expertise required to conduct and interpret the test, this price reflects the comprehensive service provided, including the genetic counseling that is often recommended to discuss the results and their implications for the individual and their family members.
The SORL1 gene, associated with early-onset Alzheimer's disease, is a focus of genetic testing aimed at identifying individuals at risk of developing this autosomal dominant form of Alzheimer's. This specific form of the disease manifests earlier than the more common late-onset Alzheimer's, often affecting individuals before the age of 65. The SORL1 gene has been identified as a significant player in the disease's pathology, influencing the processing of amyloid precursor protein, which is crucial in the development of amyloid plaques—a hallmark of Alzheimer's disease.
DNA Labs UAE offers a comprehensive genetic test targeting the SORL1 gene to determine an individual's risk of developing early-onset Alzheimer's disease. The test, priced at 4400 AED, involves a detailed analysis of the SORL1 gene to identify mutations that are known to contribute to the development of Alzheimer's disease. This predictive testing is particularly valuable for individuals with a family history of early-onset Alzheimer's, providing them with crucial information regarding their genetic predisposition to the disease.
By opting for this test, individuals can gain insights into their genetic makeup, allowing them to make informed decisions about their health and future. The results can also guide healthcare professionals in tailoring prevention strategies and early intervention plans, potentially mitigating the impact of the disease. DNA Labs UAE ensures confidentiality and accuracy, offering support and guidance throughout the testing process.
The RTN3 gene is associated with the development and progression of Alzheimer's disease, a neurodegenerative disorder characterized by cognitive decline and memory loss. Mutations or alterations in the RTN3 gene have been linked to the disease's pathology, making it a significant target for genetic testing.
DNA Labs UAE offers a specialized genetic test focused on analyzing the RTN3 gene to identify potential risks or the presence of genetic markers associated with Alzheimer's disease. This test is crucial for individuals with a family history of Alzheimer's or those experiencing early symptoms of cognitive decline, as it can provide valuable insights into their genetic predisposition to the disease.
The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for specific mutations or alterations in the RTN3 gene. The results can help guide personalized prevention strategies, early interventions, or inform patients about their risk levels, potentially leading to more targeted and effective management of the condition.
The cost of the RTN3-related genetic test at DNA Labs UAE is 4400 AED. This investment can be invaluable for individuals seeking to understand their genetic risk for Alzheimer's disease and take proactive steps towards managing their health.
The TTR Gene Amyloidosis Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the transthyretin (TTR) gene. These mutations are known to cause transthyretin amyloidosis, a rare condition characterized by the accumulation of abnormal amyloid proteins in the body's tissues and organs. This progressive disease can lead to various health issues, including neuropathy, cardiomyopathy, and gastrointestinal problems.
DNA Labs UAE offers this crucial genetic test for individuals who have symptoms of TTR amyloidosis or have a family history of the condition, providing them with essential information about their genetic status. The test involves collecting a DNA sample, typically through a blood draw, which is then analyzed in the lab for the presence of specific mutations in the TTR gene.
The cost of the TTR Gene Amyloidosis Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the TTR gene. By opting for this test, individuals can gain valuable insights into their genetic predisposition to transthyretin amyloidosis, enabling them to make informed decisions about their health and potential treatment options.
The GSN Gene Amyloidosis Finnish type genetic test is a specialized diagnostic procedure designed to identify mutations in the GSN gene, which are responsible for the development of Finnish type amyloidosis. This rare form of amyloidosis is characterized by the accumulation of abnormal amyloid proteins in various tissues of the body, leading to a wide range of symptoms including kidney problems, nerve damage, and heart issues. The test is particularly relevant for individuals of Finnish descent or those with a family history of the condition, as it can provide crucial information for early diagnosis and management.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample from the patient, typically through a blood draw or a cheek swab. The sample is then analyzed using advanced genetic sequencing techniques to detect any mutations in the GSN gene. The results of this test can help guide treatment decisions and allow for the implementation of preventive measures to manage symptoms and improve the quality of life for affected individuals.
The cost of the GSN Gene Amyloidosis Finnish type genetic test at DNA Labs UAE is 4400 AED. This price reflects the complexity of the genetic analysis and the specialized expertise required to accurately interpret the results. Patients considering this test should consult with a healthcare provider or a genetic counselor to understand its benefits and limitations in the context of their personal health history and family background.
